chrisvoncsefalvay/vaers-outcomes huggingface dataset:
12 hours after injection Band-Aid was removed and redness was noted, about the size of the bandaid. The next morning 12/30/20 the injection site was red, swollen, painful to the touch, hot, with a lump. This persisted for 2 to 3 days .  Symptoms seemed to be improving over the next 2 days and then suddenly redness at least tripled in size (maybe more), area was hot to the touch, swollen/raised like a large welt, and extremely itchy. This lasted for 3 days and then symptoms gradually improved until they resolved.
1) COVID toe became apparent 2-3 weeks after the injection - redness of the right foot, second toe accompanied by swelling of affected digit and surrounding tissue - this COVID toe appears almost identical to one patient had in early 2020 2) injection triggered PMR (polymyalgia rheumatica) relapse in right foot at same time as COVID toe appeared  3) Prednisone and Ibuprofen have lessened some of the symptoms but some swelling and discomfort remains after more than 2 weeks of relapse
Pain on the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain on the site of injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Pain on the site of injection). At the time of the report, VACCINATION SITE PAIN (Pain on the site of injection) outcome was unknown.            Concomitant medication list was not provided. Treatment information was not provided.
Light-headed, dizzy, sweating, vomiting. 911 was called and patient was taken to the hospital.
HIVES.  GIVEN BENADRYL AS TREATMENT. PATIENT DID BETTER.  DID REPORT TO LOCAL HEALTH DEPARTMENT WHO REFERRED TO CDC THEN VAERS
Patient admitted as transfer from clinic with recurrent nitro-responsive chest pain. Cardiology was consulted for unstable angina and he underwent coronary angiogram with successful angioplasty of the pLCx. He will be discharged on Pepcid 20 mg p.o. daily.  ED visit to hospital admission within 6 weeks of receiving the COVID vaccine. Additional ED visit 10 days later for chest pain. Treated and released.       Famotidine 20 mg Oral ONCE DAILY    Gentamicin Sulfate 0.1 % Apply to PD catheter site after exit site cares.    Isosorbide Mononitrate 60 mg
2 hours after Pfizer covid19 vaccine given my ears started ringing. It is constant non stop 24 hours a day everyday.
Awoke very dizzy/confused. Could not walk in straight line. Veered left/ right. Easedxas day progressed. Called EMT to rule out CO2 or any gas/ environmental issues. Far less severe than sister who was hospitalized previous day.
Massive headache; TIREDNESS; Muscle pain; fever; ears ache; nausea; chills; This is a spontaneous report from a contactable consumer, the patient. A 55-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8727), via an unspecified route of administration in the right arm on 18Mar2021 at 12:30 (at the age of 55-year-old) as single dose for COVID-19 immunisation. Medical history was not reported. The patient has allergies to codeine. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2020, the patient experienced massive headache that she couldnt get out of bed for 2 days, tiredness, muscle pain, chills, fever, ears ache, nausea for 5 days most lasted 3 to 4 days. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the reported events massive headache, tiredness, muscle pain, chills, fever, ears ache and nausea was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Shivering, teeth chattering, tired, urgent need to urinate ever hour or so for most of the night such that it disturbed sleep.  Severe symptoms lasted about 6 hours.  Sore arm and muscle aches at both injection sites.
2 days post vaccination pt noted redness and itching at site of injection - approx quarter size area. Also noted area on back of itching and small bumps or rash - sx lasted about 2 days although slight itch persists at site of injection 1 week later.
Loss of strength and mobility in arm. Shooting pain when used. Pressure and loss of strength in wrist. Severe pain at night unable to rest, unable to perform daily tasks, for the last 10 days. Have been off work due to inability to function!
given to patient under 4 years old; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 11-month-old female patient who received DTPa-IPV (Kinrix) (batch number 237C4, expiry date 17th January 2023) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 27th August 2021, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 27th August 2021, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The nurse reported that, the patient was inadvertently administered a dose of Kinrix under 4 years, which led to inappropriate age at vaccine administration. The reporter did not consent to follow up.
This case was reported by a pharmacist via call center representative and described the occurrence of general body pain in a 63-year-old female patient who received FLUARIX QUADRIVALENT (batch number 4Z27T, expiry date 25th June 2017. Concomitant products included PNEUMOVAX 23. On 23rd September 2016, the patient received FLUARIX QUADRIVALENT .5 ml. On 23rd September 2016, less than a day after receiving FLUARIX QUADRIVALENT, the patient experienced general body pain, fever, burning in eyes, headache and runny nose. On an unknown date, the outcome of the general body pain, fever, burning in eyes, headache and runny nose were not recovered/not resolved. The reporter considered the general body pain, fever, burning in eyes, headache and runny nose to be related to FLUARIX QUADRIVALENT. Additional details were provided as follows: This case was previously not reported to anyone. The age at vaccination was not reported. The patient experienced headache, runny nose, burning eyes, fever and severe body aches after vaccination with FLUARIX QUADRIVALENT in left deltoid. This case is 1 of the 4 cases reported by the same reporter.
Weakness, dizziness, lightheaded, cramps, chest pain, shortness of breath, headache.
mom reports pt ran fever of 104 for 3-5hr p/vax w/last documented DTP 17AUG92;
evening of day two (Nov 2nd) noticed soreness under left arm with armpit swelling .
Fever fatigue up to 48h after injection, arm swelling at receiving site  showing redness and hardness from today( day10 after injection),  about size of my hand , feeling itch and a little pain too.
This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 67-year-old female patient who received Shingrix for prophylaxis. On 21st August 2018, the patient received the 1st dose of Shingrix (intramuscular). In August 2018, less than a day after receiving Shingrix, the patient experienced injection site erythema, injection site lump, injection site pain and injection site warmth. On an unknown date, the outcome of the injection site erythema was not recovered/not resolved and the outcome of the injection site lump, injection site pain and injection site warmth were recovered/resolved. It was unknown if the reporter considered the injection site erythema, injection site lump, injection site pain and injection site warmth to be related to Shingrix. Additional details were provided as follows: The patient received Shingrix in the left arm. The reporter stated that, she received Shingrix vaccine and noticed the injection site had a red 2 inch circle that had been hot to the touch, felt like a lump and was sore. The symptoms started within 24 hours of receiving vaccine. The symptoms of hot to touch, soreness, and lump had resolved. The patient had provided address detail of there physician. This case has been linked with case US2018165374, reported by the same reporter.
First dose- Sore arm. Mild headache and tightness in neck/jaw for 2 weeks. Numbness and twitching in both hands.; First dose- Sore arm. Mild headache and tightness in neck/jaw for 2 weeks. Numbness and twitching in both hands.; First dose- Sore arm. Mild headache and tightness in neck/jaw for 2 weeks. Numbness and twitching in both hands.; First dose- Sore arm. Mild headache and tightness in neck/jaw for 2 weeks. Numbness and twitching in both hands.; First dose- Sore arm. Mild headache and tightness in neck/jaw for 2 weeks. Numbness and twitching in both hands.; First dose- Sore arm. Mild headache and tightness in neck/jaw for 2 weeks. Numbness and twitching in both hands.; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 05Apr2021 at 17:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient had no known allergies to medications, food, or other products. Concomitant medications taken within two weeks of vaccination were reported as not applicable. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 06:00, with first dose, the patient experienced sore arm. On 06Apr2021 at 06:00, the patient also had mild headache and tightness in neck/jaw for two weeks. The patient experienced numbness and twitching in both hands on 06Apr2021 at 06:00. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events sore arm, mild headache and tightness in neck/jaw for two weeks, numbness and twitching in both hands were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Quickly after receiving vaccine patient began feeling lightheaded/dizzy then progressed to nauseated and feeling the need to vomit. Patients temperature increased slightly to 99.4.  Placed a cool washrag on neck and gave Diphenhydramine 25mg at 12:15pm (patient stated had Benadryl at 6am at home before coming to work). Patients blood pressure was taken by parent who is a nurse at Woodridge 122/86.  At 12:57pm patients temperature returned to 97.4 and patient was improving. Patients parent gave Zofran for the nausea/vomiting feeling at 1pm. Patient was feeling better but still dizzy and patients parent took the patient home at 1:18pm.
Information has been received from a nurse practitioner, for the Pregnancy Registry for varicella virus vaccine live (Oka/Merck), concerning a 24 year old pregnant female (LMP: 23-OCT-2007) who on 29-NOV-2007 was vaccinated with her first dose of varicella virus vaccine live (Oka/Merck) (Lot # 659113/1360U) 0.5 mL IM. Concomitant therapy included prenatal vitamins (unspecified). On 11-DEC-2007 the patient had a prenatal screen blood test. The patient sought unspecified medical attention. On 14-DEC-2007 the patient was treated with nitrofurantoin (MACROBID) for a urinary tract infection. Additional information has been requested. 6/18/10 Follow up informatin was received from the nurse practitioner. It was reported that the estimated date of delivery was 04-AUG-2008 and on 03-AUG-2008 the patient had a normal spontaneous vaginal delivery of a normal infant female with no congenital anomalies weighing 7 pounds and 8 ounces. The apgar was 9/9. No further information is available.
Heart tachycardia, chest pains,orthostatic hypotention broke out in cold sweat, loss vision, fatigue Did not emergency seek medical treatment.
Pretty severe dizziness, caused stumbling and almost falling over at 2:15 AM.  At 9:20 AM, I again experienced dizziness, unsteadiness, and now "cloudy thinking" like I'm just somewhat confused...I am still feeling this way right now at 10:30 AM. 11/16/09 Medical records received for dates 6/19/09 to 11/13/09. Prenatal recs. On 11/13 Pt. presented with c/o disoriented, difficulty walking, after getting H1N1 vax. Pt seen in ER. 25wks pregnant G1P0. EDC: 2/22/10. PMH: pregnant IBS, migraines, allergy to PCN.  bhp  11/20/2009 ED records for 11/11/2009,. DC Dx Ataxia  patient with c/o's dizziness, off balance.
After flu vaccine given, patient complained of itching at the injection site approx 10 min after injection. Pt was given an ice pack.
This spontaneous report as received from a Physician Assisstant refers to a patient of unknown age. Information on medical history, past drugs, concurrent conditions and concomitant medications were not provided. On 28-FEB-2018, the patient was vaccinated with (wistar ra 27-3) M-M-R II, intramuscularly (lot# N019126, 22-JUN-2019, dose, frequency were not provided) for prophylaxis, sterile diluent (lot#, Exp date unknown, dose, frequency, indication were not specified) which were reconstituted intramuscularly for prophylaxis rather than subcutaneous (Subcutaneous injection formulation administered by other route), (inappropriate route of vaccination). Lot# N019126 has been verified to be valid lot for (wistar ra 27-3) M-M-R II.
Child presented w. generalized hives on neck, chest and general body 3 days after immuniaztions.
Fever, headache, joint pain, vomiting, tachycardia, fatigue, fainting.
Headache, top arm ache fatigue next day under armpit pain level 7 got worse and into lymph arm pit pain radatiating down nerves into left hand extreme pain throbbing for 3 days almost saw a Dr. Tuesday had appointment Wednesday already set so it was just declining 7 days later no mild armpit tenderness.
Patient received a dose of 0.2ml of Pfizer vaccine, the vaccines was not prepare correctly the diluent was not added it to the vial. He received a full dose of medication without the diluent.
Moderna COVID-10 Vaccine EUA Fever (101.0), Body aches, flu-like symptoms
This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer who reported for her husband. A male patient of an unspecified age received a single dose of PREVNAR 13, on Mar2016 for immunisation.  The patient medical history and concomitant medications were not reported.  The patient was seriously ill since receiving the vaccine in Mar2016. The outcome of the event was unknown. No follow-up attempts are possible. No further information is expected.
a week after the vaccine, the patient developed muscle pain, fatigue, nausea, headaches which are still ongoing.  The patient developed a red rash (COVID arm) 10 days after the vaccine
Hypertension + chostochondritis left ribs 1-3 Narrative:  Patient reported slightly elevated BP at 143/93 and reproducible chest pain on 1/8/2021 at 9:00am. Wanted to be examined as her 2 year boyfriend recently died of an arrhythmia. Has history of fibromyalgia and BP is "always is elevated when she see's a provider". BP improved to 138/76 on repeat after 15 min of discussion.
PEDVAXHIB had a temperature excursion and was administered; This spontaneous report was received from a nurse referring to a 4 months old patient of unknown gender. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not reported.  On 19-FEB-2021, the patient was vaccinated with improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (strength, dose, anatomical location, and route of administration were not reported, lot # T020614, expiration date 12-MAR-2023) for prophylaxis (product storage error).         The vaccine was stored in a temperature of 34.5 degrees Fahrenheit (F) for 29 minutes as recorded by a data logger. There were previous temperature excursions of 34.2 F and 35.4 F for 15 minutes.  No product quality complaint (PQC) was reported.  This is one of the several reports reported by the same reporter.; Sender's Comments:  US-009507513-2104USA001304: US-009507513-2104USA001350: US-009507513-2104USA001312: US-009507513-2104USA001282:
Information has been received from a male patient of unknown age concerning himself. On an unknown date the patient was vaccinated with a dose of PNEUMOVAX 23 (dose, route and lot# were not reported). On an unknown date the patient experienced cough. The outcome of the event was unknown. Causality was not reported. Additional information is not expected as no contact details were provided.
My lymph nodes swelled up, but I do not remember when it started but it has been like this for a few months since April. I decided to go to the doctor on June and I had to wait to get in. He did a manual examination and prescribed me an antibiotic called Azithromycin for 5 days to see if my lymph nodes will swelled down but they did not.
This spontaneous case reported by a consumer, describes the occurrence of severe depression (he felt he had no control over) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Apr 9, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On May 7, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced severe depression (he felt he had no control over). At the time of the report, severe depression (he felt he had no control over) outcome: unknown.  No concomitant medication or treatment information provided.
I had very mild nasal congestion, a cough for a day, and slight fever no higher than 101. I tested positive for COVID-19 at home. I started to feel better after 3 days but, I was still tested positive for COVID-19.
I had my 2nd shot in the evening of  Feb 13.  On Sunday in the mid afternoon around 2, I started experiencing chills and aches. I didn't feel like eating at all. I ate a little in the evening but I mainly slept the last half of the day. I took 2 Tylenol ever 4 hours and kept on that and took a Tylenol PM when I finally gave up and went to bed. Then next 3 days, throughout all these days, Mon - Wed, I had an excruciating headache and more joint pain especially in my ankles.  My headaches came from the back of my lower neck to my forehead. My entire shoulder was  sore the entire time.  I had a low grade fever only on Monday (Day 2). The injection site was red and warm to the touch the entire time. It was also very itchy and a tiny bit swollen and with a little bit of maybe a rash? I experienced chills on the first 2 days after my injection. Today is day 5 and I still continue to have gastric issues, not really wanting to eat even though I have been feeling hungry, a bit queasy throughout the 5 days. I drank peppermint tea through the past 5 days as it was the only thing that felt good in my body.  On Tuesday after too much stomach upsets, I chose to eat the BRATY and only ate bananas, yogurt, very finely chopped apples, and crackers. By Wed, I more hungry to tried to eat light and a not a lot. Today Friday, Day 5, I chose to eat some Soup and that seems OK. I still have a headache but not as severe as on Day 2 and 3. My injection site is starting to look normal.
For first 72 hours following initial injection there was normal soreness, redness at the area. Then yesterday on day eight a 3 inch diameter firm spot has appeared at the injection site. It is present with fever, rough rash and itches.
Day 1, I was able to do my morning walk, but soon after I started feeling sluggish and achy. I developed a bad headache and had a lot of symptoms similar to the flu, but no fever. My arm had a knot the size of a hardball, and just as hard, and feverish. I was able to go to work, but felt bad the entire day. Day 2, I felt much, much better, but the knot, soreness and fever were still there. I kept the knot, pain and fever for about a week total. As the days passed the knot got itchy, but no rash, until it was gone. At first it was too painful to scratch, but as the pain subsided each day I'd just massage the itch. About 10 days after taking the vaccine I developed an itchy neck and face. The front of my throat and face would get randomly itchy at all times of the day and night. No visible rash, only itchy. This continued every day. I only realized it was a reaction from the shot when I got in the shower at about day 13 or 14, and the water felt like little shots of electricity on my neck. This is the same way my husband described it when he had shingles about 24 years ago. That must have been the peak, because since that day all the itchiness seems to have lessened a little at a time. Today, at day 23, I still have some itching, but not nearly as bad as it was. I haven't regained my regular level of energy back either. I'm hoping that will return soon.
pt recvd vax & exp burning & swelling @ inject site which required tx w/ice; w/in several hrs of vax the sx subsided; The nurse then switched to a different lot# of vax & the sx did not recur; No further details were provided;
had the worst headache/The pain was awful; vomited; This is a spontaneous report from a contactable nurse. A 47-years-old female patient received second dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: En6208) via an unspecified route of administration and administered in right arm on 20Mar2021 11:45 (at age of 47 years) as single dose for COVID-19 immunization. The patient medical history include: About a year ago had low blood platelets. Asthma. HBP and No known allergies. The patients concomitant medication include hydrochlorothiazide, losartan potassium (LOSARTAN HCTZ), curcuma longa (TURMERIC [CURCUMA LONGA]), fluticasone propionate, salmeterol xinafoate (ADVAIR) and MULTIVITAMINS [ASCORBIC ACID; ERGOCALCIFEROL; FOLIC ACID; NICOTINAMIDE; PANTHENOL; RETINOL; RIBOFLAVIN; THIAMINE HYDROCHLORIDE]. No COVID prior vaccination. The patient historical vaccine included first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: En6202) via an unspecified route of administration and administered in left arm on 27Feb2021 10:15 as single dose for COVID-19 immunization. There was no other vaccine in four weeks, prior vaccination patient was not diagnosed with COVID-19 and since vaccination the patient not tested for COVID-19. The patient experienced had the worst headache/the pain was awful, had to go to ER. she do not suffer from migraines and patient experienced vomiting on 25Mar2021 at 09:30 am on Thursday-morning when she woke up. Therapeutic measures were taken as a result of headache with cocktail and Something for the vomiting. IV. The reporter considered the seriousness of events as medically significant. The outcome of events was considered as resolving.